Search research articles
Contact Us
Filters
Showing results (61-70 of 329) with videos related to
Page
of 33
Sort By:
Arthritis and Rheumatism
|
June 28, 2006
Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus
Annaliese Tisseverasinghe, Sooyeol Lim, Celia Greenwood, et al.
The Journal of Rheumatology
|
February 24, 2000
Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis
M D Lucey, M M Newkirk, C Neville, et al.
Frontiers in Immunology
|
October 31, 2018
Alpha2beta1 Integrin (VLA-2) Protects Activated Human Effector T Cells From Methotrexate-Induced Apoptosis
Amna Abderrazak, Mohammed-Amine El Azreq, Dalila Naci, et al.
The Journal of Biological Chemistry
|
April 7, 2000
The allosteric regulation of pyruvate kinase
G Valentini, L Chiarelli, R Fortin, et al.
Journal of Clinical Epidemiology
|
March 18, 2008
Patients with systemic autoimmune diseases could not distinguish comorbidities from their index disease
Marie Hudson, Sasha Bernatsky, Suzanne Taillefer, et al.
Arthritis and Rheumatism
|
February 28, 2009
Work disability in systemic lupus erythematosus
Ali M Al Dhanhani, Monique A M Gignac, Jiandong Su, et al.
Medical Care
|
June 18, 2002
Measuring clinically important changes with patient-oriented questionnaires
Matthew H Liang, Robert A Lew, Gerold Stucki, et al.
The Journal of Rheumatology
|
May 6, 1999
Discontinuation of antimalarial drugs in systemic lupus erythematosus
C Wang, P R Fortin, Y Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 20, 1998
Predictors of delay in starting radiation treatment for patients with early stage breast cancer
V Benk, V Ho, P R Fortin, et al.
Arthritis and Rheumatism
|
November 28, 2008
Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial
Paul R Fortin, Michal Abrahamowicz, Diane Ferland, et al.
Page
of 33
Search research articles
Search
Showing results (61-70 of 329) with videos related to
Sort By:
Page
of 33
Arthritis and Rheumatism
|
June 28, 2006
Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus
Annaliese Tisseverasinghe, Sooyeol Lim, Celia Greenwood, et al.
The Journal of Rheumatology
|
February 24, 2000
Association between IgM response to IgG damaged by glyoxidation and disease activity in rheumatoid arthritis
M D Lucey, M M Newkirk, C Neville, et al.
Frontiers in Immunology
|
October 31, 2018
Alpha2beta1 Integrin (VLA-2) Protects Activated Human Effector T Cells From Methotrexate-Induced Apoptosis
Amna Abderrazak, Mohammed-Amine El Azreq, Dalila Naci, et al.
The Journal of Biological Chemistry
|
April 7, 2000
The allosteric regulation of pyruvate kinase
G Valentini, L Chiarelli, R Fortin, et al.
Journal of Clinical Epidemiology
|
March 18, 2008
Patients with systemic autoimmune diseases could not distinguish comorbidities from their index disease
Marie Hudson, Sasha Bernatsky, Suzanne Taillefer, et al.
Arthritis and Rheumatism
|
February 28, 2009
Work disability in systemic lupus erythematosus
Ali M Al Dhanhani, Monique A M Gignac, Jiandong Su, et al.
Medical Care
|
June 18, 2002
Measuring clinically important changes with patient-oriented questionnaires
Matthew H Liang, Robert A Lew, Gerold Stucki, et al.
The Journal of Rheumatology
|
May 6, 1999
Discontinuation of antimalarial drugs in systemic lupus erythematosus
C Wang, P R Fortin, Y Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 20, 1998
Predictors of delay in starting radiation treatment for patients with early stage breast cancer
V Benk, V Ho, P R Fortin, et al.
Arthritis and Rheumatism
|
November 28, 2008
Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial
Paul R Fortin, Michal Abrahamowicz, Diane Ferland, et al.
Page
of 33